This translocation gives rise to the BCR/ABL fusion gene, which consequentially translates into the p210BCR/ABL oncoprotein (63, 64) in CML patients. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.